• For Supporters

Tania Bryer: “Mum was lucky enough to benefit from research. Others aren’t as fortunate”

Before we entered lockdown, we caught up with broadcaster, philanthropist and Chair of our National Events Committee, Tania Bryer. Before we entered lockdown, we caught up with broadcaster, philanthropist and Chair of our National Events Committee, Tania Bryer.

12 May 2020

• For Researchers

Researcher voices: Early-career researchers in the time of COVID-19

Meet 6 early-career cancer researchers living and working through the COVID-19 pandemic. Meet 6 early-career cancer researchers living and working through the COVID-19 pandemic.

7 May 2020

• For Researchers

Marcel Gehrung: the many hats of an entrepreneur at home

PhD student Marcel Gehrung is writing up his thesis, setting up a spin-out company and supporting the response to the coronavirus (COVID-19) crisis. PhD student Marcel Gehrung is writing up his thesis, setting up a spin-out company and supporting the response to the coronavirus (COVID-19) crisis.

5 May 2020

• Health & Medicine

Coronavirus and cancer – May updates

We’re pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer from May. We’re pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer from May.

4 May 2020

• Health & Medicine

News digest – cancer blood test, prostate cancer treatment, cancer risk and breast cancer radiotherapy

A targeted cancer drug, already used to treat some breast and ovarian cancers, has also been found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already used to treat some breast and ovarian cancers, has also been found to be effective for some men with advanced prostate cancer.

2 May 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• For Researchers

We support Plan S principles and will adopt an immediate open access policy from January 2022

We’re changing our open access policy, ensuring immediate open access for all CRUK-funded articles accepted for final publication on or after 1 Jan 2022. We’re changing our open access policy, ensuring immediate open access for all CRUK-funded articles accepted for final publication on or after 1 Jan 2022.

30 April 2020

• Personal Stories

Coronavirus reports – Part 1: “I’m taking things week by week”

We caught up with several people around the country who live with cancer, to find out how the pandemic was affecting them. We caught up with several people around the country who live with cancer, to find out how the pandemic was affecting them.

27 April 2020

• Health & Medicine
• Science & Technology

News digest – targeted treatment approval, prostate cancer deaths and antlers?

A 'breakthrough' targeted cancer drug has been approved for NHS use in England. A 'breakthrough' targeted cancer drug has been approved for NHS use in England.

25 April 2020